PT Kalbe Farma Tbk.

OTCPK:PTKF.Y Stock Report

Market Cap: US$4.0b

Kalbe Farma Management

Management criteria checks 2/4

We currently do not have sufficient information about the CEO.

Key information

Bernadette Ruth Setiady

Chief executive officer

n/a

Total compensation

CEO salary percentagen/a
CEO tenureno data
CEO ownership0.05%
Management average tenure3.3yrs
Board average tenure6yrs

Recent management updates

Recent updates

CEO

Bernadette Ruth Setiady (62 yo)

no data

Tenure

Mrs. Bernadette Ruth Irawati Setiady had been President Commissioner of PT Kalbe Farma Tbk. since June 5, 2017. Mrs. Setiady serves as the President Director at PT.Kalbe Farma Tbk. In 1987, she began her...

Leadership Team

NamePositionTenureCompensationOwnership
Bernadette Ruth Setiady
President Directorno datano data0.047%
$ 1.9m
Sie Djohan
Director of Corporate Business Development18.3yrsno datano data
Rustam Tan
Head of Internal Audit Unit3.3yrsno datano data
Maria Fabiola
Corporate Secretary2.3yrsno datano data

3.3yrs

Average Tenure

55.5yo

Average Age

Experienced Management: PTKF.Y's management team is considered experienced (3.3 years average tenure).

Board Members

NamePositionTenureCompensationOwnership
Bernadette Ruth Setiady
President Directorno datano data0.047%
$ 1.9m
Sie Djohan
Director of Corporate Business Development7.9yrsno datano data
. Vidjongtius
President Commissionerno datano datano data
Santoso Oen
Commissioner17.3yrsno data0.093%
$ 3.7m
Rhenald Kasali
Independent Commissionerno datano datano data
Ronny Hadiana
Commissioner10yrsno data0.20%
$ 8.1m
Jos Atmadjaja
Director4yrsno datano data
Lilis Halim
Independent Commissioner6yrsno datano data
. Mulialie
Director4yrsno data0.00055%
$ 22.0k
Kartika Setiabudy
Director2.3yrsno datano data

6.0yrs

Average Tenure

58.5yo

Average Age

Experienced Board: PTKF.Y's board of directors are considered experienced (6 years average tenure).

Company Analysis and Financial Data Status

DataLast Updated (UTC time)
Company Analysis2025/05/10 08:16
End of Day Share Price 2025/05/05 00:00
Earnings2025/03/31
Annual Earnings2024/12/31

Data Sources

The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.

PackageDataTimeframeExample US Source *
Company Financials10 years
  • Income statement
  • Cash flow statement
  • Balance sheet
Analyst Consensus Estimates+3 years
  • Forecast financials
  • Analyst price targets
Market Prices30 years
  • Stock prices
  • Dividends, Splits and Actions
Ownership10 years
  • Top shareholders
  • Insider trading
Management10 years
  • Leadership team
  • Board of directors
Key Developments10 years
  • Company announcements

* Example for US securities, for non-US equivalent regulatory forms and sources are used.

Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more.

Analysis Model and Snowflake

Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.

Learn about the world class team who designed and built the Simply Wall St analysis model.

Industry and Sector Metrics

Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on Github.

Analyst Sources

PT Kalbe Farma Tbk. is covered by 32 analysts. 14 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.

AnalystInstitution
Helmy KristantoBNP Paribas Securities (Asia)
Swati ChopraBofA Global Research
Jason ChandraCGS International